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Abstract
Background:  Research has shown that many healthcare professionals have problems with
guidelines as they would prefer to be given all relevent information relevent to decision-making
rather than being told what they should do. This study assesses doctors' judgement of the validity,
relevance, clarity and usability of the Italian translation of Clinical Evidence (CE) after its free
distribution launched by the Italian Ministry of Health
Methods: Opinions elicited using a standardised questionnaire delivered either by mail or during
educational or professional meetings
Results: Twenty percent (n = 1350) doctors participated the study. Most of them found CE's
content valid, useful and relevant for their clinical practice, and said CE can foster communications
among clinicians, particularly among GPs and specialists. Hospital doctors (63%) more often than
GPs (48%) read the detailed presentation of individual chapters. Twenty-nine percent said CE
brought changes in their clinical practice. Doctors appreciated CE's nature of an evidence-based
information compendium and would have not preferred a collection of practice guidelines.
Conclusions: Overall, the pilot initiative launched by the Italian Ministry of Health seems to have
been well received and to support the subsequent decision to make the Italian edition of Clinical
Evidence concise available to all doctors practising in the country. Local implementation initiatives
should be warranted to favour doctor's use of CE.
Background
While there is a wide consensus that information on the
effectiveness of health care interventions should be, as
much as possible, evidence-based, it is common experi-
ence that many important questions doctors face in clini-
cal practice do not have such information[1].
Moreover, research on health services and quality of care
have consistently demonstrated that the availability of
good quality information is an essential yet insufficient
condition for enhancing doctors' adherence to evidence-
based practices[2]. Some have argued that, in order to be
usable, information should be credible and independent
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from commercial interests, relevant and applicable in
clinical practice and be delivered within a context (i.e cul-
tural organisational, etc.) that favours its adoption and
implementation.
Some ten years ago the Cochrane Collaboration took the
challenge of producing, maintaining and disseminating
the results of high quality systematic reviews of the effects
of health care interventions[3]. However, Cochrane
reviews are sometimes evidence-rather than question-
driven and their format is more appropriate for research-
ers than for those who need practical guidance at the time
health care decisions are taken. Evidence based practice
guidelines (PGs), as well as other tools (such as clinical
pathways, etc) have also attracted substantial interest and
investments but research has shown that PGs represent
tools many health care professionals have problems with
[4-6] and their impact has been shown to be generally
modest.
In 1995 the BMJ Publishing Group launched Clinical Evi-
dence (CE), a compendium summarising the best availa-
ble evidence of the effects of health care interventions,
published and updated twice a year[7-9]
Key distinguishing features of Clinical Evidence are that [7]:
• its contents are driven by practical questions rather than
by the availability of research evidence;
• it aims not to make recommendations (unlike PGs) but
to inform health professionals on the best available
evidence;
• it highlights rather than hiding gaps in research evi-
dence, so that physicians know when their uncertainty
stems from these gaps rather than from gaps in their own
knowledge.
In response to the need for more general, good quality
and updated information the General Directorate for
Drug Evaluation and Surveillance of the Italian Ministry
of Health launched, at the end of the end of the '90s, the
"National Program for Independent Information (NPII)"
with a funding that since 2001 amounts to approximately
50 million Euro. The NPII has an infrastructure compris-
ing two monitoring centres and foresees the regular the
dissemination of various information tools.
The two centres are the "Osservatorio dei Medicinali
(OsMed" aimed at providing annual feedback on profiles
of drug utilisation and the "Osservatorio Sperimentazioni
Cliniche" reporting information on clinical trials and clin-
ical research approved by Italian Research Ethics Commit-
tees). The dissemination activity included the translation
and free distribution to health professionals of three refer-
ence books – British National Formulary; Medicines for Chil-
dren and Clinical Evidence (CE). The latter was introduced
gradually with a first pilot distribution – whose evaluation
is the subject of this article – took place in 2001. Still as
part of the information dissemination activities a
bimonthly journal on drug efficacy and safety, "Bollettino
di Informazione sui Farmaci" (BIF) [10], is delivered to all
physicians (300.000) and pharmacists (60.000). The
implementation of a unified web reference source where
different information tools will be made available to all
health professionals within the country is currently under
discussion.
Methods
CE was freely distributed to 43.000 doctors (i.e. 15% of
the total practising in 10 Italian regions). After one or
more public presentations organised by the local depart-
ments of health, the volume was mailed to a sample of
individual doctors chosen as target for the pilot
experiment.
The evaluation was carried out using a standardised ques-
tionnaire developed by the Italian Cochrane Centre
(ICC), with the help of 30 members of the scientific com-
mittee of CE's Italian edition, and tested for face validity
within a small group of 8 GPs not subsequently involved
into the study. The final version of the questionnaire
(Appendix, see additional file 1) included 17-items
exploring frequency of use as well as opinions about the
scientific validity, clarity, relevance and readability of the
book. The final section explored whether responders con-
sidered CE as a collection of guidelines or a source of evi-
dence based information. The questionnaire was
delivered to a total of 6619 physicians (GPs, hospital-
based and other specialists, doctors working into hospital
management units ("Direzioni Sanitarie") 3–6 months
after the delivery of the book. The sample was not selected
with a formally randomised method but was drawn from
a list of active doctors, stratified by region, provided by
regional and local health departments. In three regions
questionnaires were mailed by regional health depart-
ments, in one by investigators in charge to each local
health unit while for the remaining six regions they were
mailed centrally by the Italian Cochrane Centre. All ques-
tionnaires were anonymous and no follow up mailing
was attempted after the first delivery.
Results
Overall 20% (n = 1350) physicians filled out the ques-
tionnaire with marked regional variations in response
rates (range= 8%-31%). Three-quarters respondents were
males, 63% GPs and 23% hospital clinicians. Median
time since graduation was 23 years.BMC Health Services Research 2003, 3 http://www.biomedcentral.com/1472-6963/3/24
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Most respondents (84%) used CE at least once in the
month prior to the survey (41% once or twice, 23% about
five times and 10% at least twice a week). Professional
continuing education and search for solutions to specific
clinical questions were the main reported reasons for con-
sultation (Table 1).
Most respondents considered CE very/fairly understanda-
ble and useful, and its scientific contents very/fairly valid
(Table 1). Its thoroughness was considered "just right" by
90%. More than half (53%) read the detailed presentation
of the chapters, whereas 43% focused on key messages
and 64% said that they looked only at the conclusions
(Table 2); the chapter on cardiovascular diseases being the
most commonly read (Table 3).
Twenty-nine percent said they had changed their practice
after reading CE; 28% said they learned that several com-
mon health care interventions are not evidence-based and
10% said that by consulting the book they realised that
some effective interventions may be underused. CE was
also seen by 54% as a useful tool for improving inter-pro-
fessional collaboration between GPs and specialists. Sixty-
four percent indicated that they value evidence-based
information more than guidelines. However, 38% of the
respondents still classified CE as a collection of
guidelines.
Years since graduation and perception of CE as a book of
guidelines did not predict for differences in opinions. CE
was felt more useful by GPs than hospital specialists
("very useful" for 23% vs. 14%, p < 0.01) and GPs also
reported more often to have changed their practice after
reading CE (33% vs.  23%, p < 0.01). Hospital based
doctors reported to have read the detailed presentation of
the chapters more often than GPs (63% vs. 47.6%, p <
0.01) (Table 2).
Table 1: Respondents' opinions about CE (n° responses)
Very Fairly Little Not at all Don't know
Are CE contents comprehensible? (1110) 26.0 65.9 6.4 1.6 0.2
In your opinion, are CE contents scientifically valid? (1101) 27.7 68.0 3.4 0.7 0.2
Considering your practice, has CE consultation been generally useful? (1096) 20.4 68.2 8.5 2.3 0.6
useful for keeping updated (992) 38.9 54.7 4.6 1.3 0.4
useful for getting information about specific questions (941) 34.8 57.4 6.2 1.3 0.4
useful for preparing seminars/publications (443) 18.7 34.3 24.2 7.7 15.1
Table 2: Sections read by professional setting (% responders)
CE'S SECTIONS READ PROFESSIONAL CATEGORY
General practitioners Hospital doctors All
Questions and interventions 64.5 61.5 63.8
Key messages 41,0 44.7 43.4
Detailed presentation 47.6 * 63.0* 53.1
* p < 0.01
Table 3: Chapters read (% responders)
Cardiovascular disorders 59,2
Digestive diseases 32,3
Infectious disorders 31,0
Respiratory disorders 30,1
Muscoloskeletal disorders 29,4
Endocrine disorders 22,4
Neurological disorders 21,3
Skin disorders 18,6
Mental health 18,4
Child health 15,4
Kidney disorders 14,9
Ear, nose and throat disorders 14,8
Pregnancy and childbirth 9,6
Poisoning 8,6
Men's health 8,3
Eye disorders 7,1
Sexual health 5,8
Oral health 3,4
* p < 0.01BMC Health Services Research 2003, 3 http://www.biomedcentral.com/1472-6963/3/24
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Although more than half (54%) respondents came from
one region (Emilia-Romagna) which also yielded the best
response rate (31%), results showed the same qualitative
directions and did not vary appreciably among different
regions
Discussion
Italian clinicians seem to consider CE a clear, valid and
useful source of clinical information. Three main findings
should be highlighted. First, CE seems to affect doctors'
awareness about the efficacy and safety of some health
interventions and, most importantly, to make them will-
ing to consider changes in their clinical behaviour. This
seemed true especially among GP's. Second, CE is deemed
to foster communication between GPs and specialists by
creating a common knowledge ground; this might help
smoothing the interface between primary and secondary
care and improving overall patient care. Third, our data
suggest that the original objective of the book – ie provid-
ing information rather than making clinical recommenda-
tions [5] – may be achieved. The majority of respondents
stated a preference for evidence-based summaries over
guidelines, confirming that the latter are sometimes not
easy to be accepted by doctors.
This pilot, free distribution of CE to Italian doctors seems
to have been well received, confirming their preference for
problem-driven information and the key-role of a strong
endorsement from Health Authorities for the implemen-
tation of this information. Local implementation initia-
tives should be warranted to favour doctors' use of CE (for
example through pharmacists outreach visits and Contin-
uing Medical Education programs). Recognising the value
of promoting information independent from the drug
industry [11] and also thanks to the encouraging results of
this survey the Italian Ministy of Health is continuing –
though the NPII briefly described in the introduction sec-
tion of this article – this initiative. Between July and Sep-
tember 2003 all 300.000 Italian doctors have received a
free copy of CE's second Italian edition, based on CE issue
7, in the Concise format. This relevant investment, coming
to 1,900,000 Euro (the previous translation and distribu-
tion evaluated here cost instead 770,000 Euro) indeed
pales when compared to the 575 times larger investment
(1,093 million Euro) made by pharmaceutical companies
for medical information in 2002 only [12].
In interpreting the results of this study some limitations
should be considered. As in most surveys, and considering
the low response rate, selection bias cannot be ruled out
as those more interested in using CE may have been more
willing to respond. However, 17% of the total sample (i.e.
84% of the total of 20% responders) used Clinical Evi-
dence "at least once" in the month prior to the survey and
6% (29% of the 20% responders) said they had changed
their practice after reading it. This means that the free dis-
tribution of CE and the endorsement of the Italian NHS
seem justified even in the "worst case scenario" (ie assum-
ing that all non responders did not open the book at all).
Further more qualitative evaluations will be carried out in
the future to better explore CE's usefulness and these
evaluations will hopefully be conducted internationally
as Clinical evidence is now available in several languages
other than English (Spanish, French, German, Russian,
Japanese). Another limiting factor is that more than half
respondents came from one region. However, this latter
seems unlikely to have affected our results given that the
regional subgroup with the highest response rate yielded
results similar to those of the whole sample. Finally,
although a positive attitude towards CE emerged, still
38% of responders classified it as a collection of guide-
lines. This may call for a greater effort to clarify the nature
of CE in order to improve its acceptability and to decrease
the likelihood that its users see it as a prescriptive rather
than an informative source of data.
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